Rachel Cohrs Zhang reports agency leaders are trying to square Kennedy's plan to widen peptide access with concerns from FDA scientists.
Recap by typeshit. Post by Rachel Cohrs Zhang on X.
2:06:18
A live Q&A from FitFlavorFun taking viewer questions on Zepbound, Ozempic, Wegovy, retatrutide and Korglutide.
People familiar with the matter say the plan under review includes more safeguards for patients than first expected. A policy step worth watching.
Celebrity paparazzi item on Amanda Bynes stepping out in a miniskirt, framed around her reported Ozempic use. Little detail beyond the photos.
The show is collecting experiences from people microdosing GLP-1 drugs, including why they tried it and how they got the medication.
An investor explainer on how the peptide market reaches past GLP-1 weight loss drugs.
The Illinois governor is open about his GLP-1 use, a Facebook post notes, framing it as a response to jabs from the current president.
Loading…